Biogen Pharmachem Industries Valuation

Is 531752 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

1/6

Valuation Score 1/6

Below Fair Value
Significantly Below Fair Value
Price-To-Book vs Peers
Price-To-Book vs Industry
Price-To-Book vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 531752 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate 531752's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate 531752's fair value for valuation analysis.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 531752?

Key metric: As 531752 is unprofitable and pre-revenue we use its Price-To-Book Ratio for relative valuation analysis.

The above table shows the Price to Book ratio for 531752. This is calculated by dividing 531752's market cap by their current book value.
What is 531752's PB Ratio?
PB Ratio	1.5x
Book	₹553.65m
Market Cap	₹828.81m

531752 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	-56.5x
Enterprise Value/EBITDA	n/a
PEG Ratio	n/a

Price to Book Ratio vs Peers

How does 531752's PB Ratio compare to its peers?

The above table shows the PB ratio for 531752 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PB	Estimated Growth	Market Cap
Peer Average	0.7x
526921 Twentyfirst Century Management Services	1.1x	n/a	₹1.0b
530045 Titan Securities	1.1x	n/a	₹1.1b
538609 Gajanan Securities Services	0.4x	n/a	₹428.1m
511000 Madhusudan Securities	0.3x	n/a	₹305.2m
531752 Biogen Pharmachem Industries	1.5x	n/a	₹828.8m

Price-To-Book vs Peers: 531752 is expensive based on its Price-To-Book Ratio (1.5x) compared to the peer average (0.7x).

Price to Book Ratio vs Industry

How does 531752's PB Ratio compare vs other companies in the IN Capital Markets Industry?

34 Companies	Price / Book	Estimated Growth	Market Cap
MAHSCOOTER Maharashtra Scooters	0.4x	n/a	US$1.28b
PILANIINVS Pilani Investment and Industries	0.4x	n/a	US$791.33m
503681 Elcid Investments	0.3x	n/a	US$524.01m
532256 Nalwa Sons Investments	0.2x	n/a	US$496.69m

34 Companies		Estimated Growth	Market Cap

No more companies

Price-To-Book vs Industry: 531752 is good value based on its Price-To-Book Ratio (1.5x) compared to the Indian Capital Markets industry average (1.5x).

Price to Book Ratio vs Fair Ratio

What is 531752's PB Ratio compared to its Fair PB Ratio? This is the expected PB Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

531752 PB Ratio vs Fair Ratio.
Fair Ratio
Current PB Ratio	1.5x
Fair PB Ratio	n/a

Price-To-Book vs Fair Ratio: Insufficient data to calculate 531752's Price-To-Book Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

Manappuram Finance

₹131.2b

A gold loan non-banking financial company, provides retail credit products and financial services in India.

531213

₹155.05

0.1%

-4.2%

Aditya Birla Capital

₹503.6b

Through its subsidiaries, provides various financial products and services in India and internationally.

ABCAPITAL

₹193.31

4.6%

14.3%

Five-Star Business Finance

₹188.5b

Operates as a non-banking financial company in India.

FIVESTAR

₹644.45

1.3%

-13.3%